TEAM.

ADVISORS.

COUNSEL.

PROVIDERS.

Arterez management team, advisors, providers and counsel were carefully selected to guide our technologies as well as business growth and partnership objectives.

Management Team

Dr. Joe Tunac

Chairman and President

Dr, Tunac's Bio

Dr. Tunac is a medical scientist specializing in the discovery and development of drugs and has 40 years of drug development experience for Merck, Warren Lambert Park Davis, Fermical and Farmaceutix where he discovered the anti-embolic mechanism. 30+ patents and patents pending and more than 35 scientific publications. Graduate studies at S. Dakota St. and Penn St., doctorate from Rutgers, NJ; The Waksman Institute: the birthplace of antibiotics

AAEAAQAAAAAAAA0eAAAAJDhhYTE5MzY0LTY4YmYt

Mike Brennan

Chief Executive Officer

Mike's Bio

Mike is a serial entrepreneur and team leader with 15 years experience managing 24/7 high-tech operations followed by 15 years of entrepreneurship and strategic advisory leading, funding, growing and commercializing innovations across the spectrum of industries and technologies including startups and turnarounds. Mike graduated from The University of Detroit Jesuit (go Cubs), and attended Western Michigan; Psychology/Business Admin, U of D Mercy; Cam Design and the University of Michigan; Entrepreneurial Development program.

AAEAAQAAAAAAAAbSAAAAJDZkMzAyOTc3LTlmYjQt

Brett Homovec

Chief Financial Officer

Brett's Bio

Brett gained his Corporate Finance/Mergers and Acquisitions experience as a VP in the Investment Banking Group for Rodman & Renshaw in New York and Chicago, Senior Associate in the Dean Witter Reynolds Corp Finance Group and as an audit professional for Touche Ross & Co. in New York. Brett graduated from Dartmouth College with a B.A. in Economics and received his MBA in Finance from New York University - Stern School of Business.

4D BioNexus

Diagnostic Development and Regulatory Advisor

BioNexus brings 29 years of biomedical research, business, academic, pharmaceutical and regulatory experience. 4D's director and PhD attended Eastern Michigan University and completed his doctoral studies at the University of Texas, Southwestern with post-doctoral training at the University of Arizona. He served at the UM Medical School with a joint appointment in Anesthesiology and Pharmacology before moving to Pfizer as a clinical scientist and also served as a director leading diagnostic development and assessments.

Ken's Bio

Clinical and Regulatory Advisor

Bonnie is board certified in internal medicine, cardiovascular diseases (ABIM and NBPAS) and interventional cardiology (NBPAS). She holds a Master of the Society for Cardiac Angiography and Interventions (SCAI), and is a Fellow of the American College of Cardiology, the Council on Clinical Cardiology and the American Heart Association. She is a past President of SCAI. She has been the Principal Investigator for many industry and government sponsored research activities for pharmaceuticals, medical devices and connected health societies and has been instrumental in the design and execution of clinical trials leading to regulatory approvals and post market data acquisition and serves on the board of the National Board of Physicians and Surgeons (NBPAS).

Bonnies Bio